Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

Share Price is delayed by 15 minutes
Get Live Data
32.00    -0.75 (-2.29%)
Bid:
31.00
Ask:
33.00
Spread: 2.00 (6.452%)
Market Cap: £57.87m
IKA Live PriceLast checked at - London Stock Exchange

Intraday Ilika Plc Share Chart

Goliath Scale-up Update

4 May 2022 07:00

RNS Number : 1690K
Ilika plc
04 May 2022
 

Ilika plc

("Ilika" or the "Company")

 

Goliath Scale-up Update

Scale-up plans validated - highlighting cost-saving benefits at higher volume production levels

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces the successful conclusion of its scale-up study, SOLSTICE, with partner Comau, part of Stellantis, and a world leader in the industrial automation field. The study reviewed Ilika's existing Goliath pre pilot line and delivered a plant design for a Goliath manufacturing line at a mega-scale facility (the "Project"). As reported by the company on 6th April 2021, the 12-month Project was supported by the Advanced Propulsion Centre (APC) and Ilika received a £276,000 grant towards costs related to the Project.

The Project had two objectives, firstly a review and subsequent validation of Ilika's internal plan to scale up its facility from a production capacity of 50kWh per year to 2MWh per year. Following on from the review, Ilika has a detailed facility and equipment plan and has entered into discussions with equipment vendors, with the first long lead time equipment orders expected to be placed in Q2 2022. Ilika's 2MWh scale up will deliver and commission a fully operational facility by Q4 2023. In the meantime, the development of Ilika's Goliath solid-state battery technology continues in accordance with the Company's technology roadmap.

The second objective of the Project was an initial review of Ilika's defined manufacturing process to assess its suitability for megawatt scale up. The Project concluded there were no cost or technical barriers to scale up, and indeed important manufacturing benefits were identified, such as an accelerated formation stage relative to traditional lithium-ion, which has the potential to significantly reduce formation times. Comau has produced a high-level costed plant design for the megawatt scale solid-state manufacturing line which will be further refined in future planned collaborations.

Automotive Transformation Director at the APC, Julian Hetherington said: "The UK has a long legacy of automotive manufacturing success and the industry now needs to scale up, at pace, to net-zero emission technologies. We are delighted that the funding awarded to Ilika and Comau through the Automotive Transformation Fund has successfully supported collaborative product and manufacturing process development that can unlock routes to subsequent investment in scaled- up facilities."

John Coombes, managing Director of Comau UK stated: "This project represented an integral part of the Comau Journey in Electrification, developed with the contribution of the internal Battery Cells Global Competence Center. We are proud of the collaboration we have had with Ilika and the APC, and also the ability to demonstrate the value our capabilities can contribute in this field. "

Graeme Purdy, Ilika CEO, stated: "This project has successfully validated Ilika's scale-up plans for its Goliath technology, highlighting some important cost-saving benefits at higher volume production levels which pave the way to gigawatt scale manufacturing. Working with Comau, one of the world's leading designers of innovative engineering solutions, has delivered a robust plan to scale-up Ilika's manufacturing capability for Goliath solid-state batteries to the next level."

 

For more information contact:

Ilika plc

Graeme Purdy, Chief Executive

Steve Boydell, Finance Director

+44 (0)23 8011 1400

 

 

 

 

Liberum Capital Limited

Andrew Godber, Cameron Duncan,

William Hall, Nikhil Varghese

+44 (0) 20 3100 2000

 

 

 

Berenberg (Joint Broker)

Emily Morris, Detlir Elezi,

Milo Bonser, Mara Grasso

+44 (0) 20 3207 8700

 

Walbrook PR Ltd

+44 (0)20 7933 8780 or ilika@walbrookpr.com

Lianne Applegarth

Mob: +44 (0)7584 391 303

Nick Rome

Mob: +44 (0)7748 325 236

Tom Cooper

Mob: +44 (0)7971 221 972

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKNBNPBKDKPK
Date   Source Headline
17th Sep 20134:09 pmRNSResult of AGM
17th Sep 20137:00 amRNSAGM Statement
16th Sep 20137:00 amRNSTwo New Customers in Europe
23rd Aug 20131:25 pmRNSPosting of Annual Report & Notice of AGM
2nd Aug 20135:02 pmRNSConversion of Securities
30th Jul 20137:00 amRNSContract Renewals and Grant Award
19th Jul 20132:50 pmRNSHolding(s) in Company
19th Jul 201311:17 amRNSHolding(s) in Company
18th Jul 20137:00 amRNS£3.3 million EPSRC Grant Award to Southampton Univ
15th Jul 20137:00 amRNSFinal Results
21st May 20131:09 pmRNSHolding(s) in Company
20th May 20137:00 amRNSDirectorate Change and Conversion of Securities
17th May 20133:57 pmRNSPlacing - Replacement
17th May 20137:00 amRNSPlacing
1st May 20137:00 amRNSFuel Cell Catalyst Patent Granted in Japan
22nd Apr 20137:00 amRNSContract with new European Customer
16th Apr 20137:00 amRNSTrading Update
21st Feb 20137:00 amRNSRenewal of Contract
29th Jan 20137:00 amRNSCompletion of Laboratory Facility Expansion
18th Jan 20133:28 pmRNSHolding(s) in Company
17th Jan 20135:46 pmRNSHolding(s) in Company
17th Jan 201311:16 amRNSHolding(s) in Company
15th Jan 20135:21 pmRNSHolding(s) in Company
10th Jan 20137:00 amRNSInterim Results
21st Dec 20127:00 amRNSGrant of Fuel Cell Catalyst Patent
18th Dec 20121:41 pmRNSCompletion of Disposal
17th Dec 20127:00 amRNSConversion of Securities
11th Dec 20127:00 amRNSRenewal of Contract
29th Nov 20124:44 pmRNSHolding(s) in Company
28th Nov 20125:00 pmRNSHolding(s) in Company
27th Nov 20122:18 pmRNSHolding(s) in Company
19th Nov 20127:00 amRNSEnergizer Relationship Update
22nd Oct 20127:00 amRNSTrading Update
5th Oct 20127:00 amRNSHolding(s) in Company
5th Oct 20127:00 amRNSTotal Voting Rights
18th Sep 20127:00 amRNSDiscontinuing of wound care products and services
14th Sep 20127:00 amRNSCarbon Trust Investment
7th Sep 20121:27 pmRNSResult of AGM
7th Sep 20127:00 amRNSAGM Statement
9th Aug 20127:00 amRNSPosting of Annual Report & Notice of AGM
19th Jul 20127:00 amRNSFinal Results
14th Jun 20127:14 amRNSChange of Adviser
1st Jun 201210:01 amRNSTotal Voting Rights
18th May 20127:00 amRNSTrading Update
17th May 20127:00 amRNSConversion of Securities
2nd May 20127:00 amRNSVapour Deposition Method US Patent Grant
1st May 20123:00 pmRNSHolding(s) in Company
30th Apr 201210:27 amRNSDirector's Dealings
30th Apr 201210:22 amRNSTotal Voting Rights
25th Apr 20122:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.